| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $7,529,945 ) |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01OH012485 | Grief and health-related quality of life in WTCHR Survivors: Associations with bereavement, trauma exposures, and mental and physical health conditions | 00 | 3 | CDC | 4/2/2024 | $499,343 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01CA255232 | Isoform-specific signaling as a determinant of RAS-driven oncogenesis | 000 | 3 | NIH | 1/25/2024 | $313,951 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R00HD099520 | Molecular analysis of MEHMO syndrome mutations in translation factor eIF2 | 000 | 4 | NIH | 11/14/2023 | $220,513 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01HL167048 | COVID-19 airway inflammation is due to Spike inhibition of CFTR signaling | 000 | 2 | NIH | 12/22/2023 | $527,792 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI155983 | Evaluation of Antibody Responses Elicited by Zika Vaccination in Flavivirus-na?ve and -experienced Individuals | 001 | 4 | NIH | 2/28/2024 | $743,136 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01GM114173 | Evolution of Homologous Recombination Mechanisms | 000 | 8 | NIH | 2/16/2024 | $279,194 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01NS119594 | Calcium Dysregulation and Cell Function in Spinal Muscular Atrophy | 001 | 4 | NIH | 4/18/2024 | $26,686 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01NS119594 | Calcium Dysregulation and Cell Function in Spinal Muscular Atrophy | 000 | 4 | NIH | 12/29/2023 | $343,117 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI147627 | Plasmodium falciparum gametocytogenesis in vitro and in vivo | 000 | 5 | NIH | 11/24/2023 | $448,809 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R35GM139619 | Temporal and Metabolic Regulation of Restimulation-Induced Cell Death (RICD) in Human T Cells | 000 | 4 | NIH | 12/11/2023 | $343,117 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01AI135941 | Targeting HIV reservoirs in children with HIVIS DNA and MVA-CMDR vaccines | 000 | 7 | NIH | 3/26/2024 | $898,170 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01GM117155 | Regulation of microtubule organizing centers during mammalian gametogenesis | 000 | 10 | NIH | 12/4/2023 | $307,860 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 002 | 11 | NIH | 11/2/2023 | $134,429 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | The Military HIV Research Program (MHRP) Clinical Trial Unit | 002 | 11 | NIH | 11/2/2023 | $639,502 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI177698 | Maturation of human humoral immunity through repeat malaria challenges | 000 | 2 | NIH | 4/5/2024 | $788,047 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21MH132136 | Intrinsic CRF signaling within the lateral habenula | 000 | 2 | NIH | 2/27/2024 | $170,845 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI173635 | HTLV-1 Replication/Reactivation-Induced DNA Damage: Mechanisms and Pathogenesis | 000 | 2 | NIH | 10/24/2023 | $170,845 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI173635 | HTLV-1 Replication/Reactivation-Induced DNA Damage: Mechanisms and Pathogenesis | 001 | 2 | NIH | 11/27/2023 | $0 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01CA255232 | Isoform-specific signaling as a determinant of RAS-driven oncogenesis | 001 | 3 | NIH | 4/16/2024 | $17,443 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21CA267515 | Preventing Therapeutic Resistance in RAS-mutated Pediatric Cancers | 000 | 3 | NIH | 1/16/2024 | $164,671 |
| | 2024 | 2023 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AA029782 | Thalamostriatal circuit contributions to behavioral inflexibility following adolescent ethanol exposure | 001 | 2 | NIH | 11/9/2023 | -$219,213 |
| | 2024 | 2023 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI155983 | Evaluation of Antibody Responses Elicited by Zika Vaccination in Flavivirus-na?ve and -experienced Individuals | 000 | 3 | NIH | 12/5/2023 | $0 |
| | 2024 | 2023 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI154619 | Respiratory mucosal immune development in early life and the quest for protective local memory against respiratory syncytial virus. | 000 | 3 | NIH | 3/29/2024 | $0 |
| | 2024 | 2023 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21NS120628 | Lateral habenula circuit dysregulation in mild traumatic brain injury | 000 | 2 | NIH | 2/29/2024 | $0 |
| | 2024 | 2023 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI168295 | Mechanistic elucidation of pathogenic CBM complex mutations associated with atopic disease | 000 | 1 | NIH | 4/18/2024 | $0 |
| | 2024 | 2023 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI176520 | Designing HIV-1 envelope immunogens to maximize neutralization breadth through use of multiple founder envelope antigens | 000 | 1 | NIH | 1/31/2024 | $0 |
| | 2024 | 2023 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01MH130197 | Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence | 001 | 2 | NIH | 4/4/2024 | $571,837 |
| | 2024 | 2023 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01MH130197 | Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence | 001 | 2 | NIH | 4/4/2024 | $594,027 |
| | 2024 | 2023 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01OH012485 | Grief and health-related quality of life in WTCHR Survivors: Associations with bereavement, trauma exposures, and mental and physical health conditions | 00 | 3 | CDC | 4/2/2024 | $0 |
| | 2024 | 2022 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AA029782 | Thalamostriatal circuit contributions to behavioral inflexibility following adolescent ethanol exposure | 000 | 1 | NIH | 11/9/2023 | -$44,130 |
| | 2024 | 2022 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | F31MH129104 | Examining Suicide Risk from a Biopsychosocial Framework: A Large-Scale Cross-Sectional Study | 000 | 1 | NIH | 3/21/2024 | -$5,582 |
| | 2024 | 2022 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI156357 | Contribution of Helicobacter pylori HomA and HomB to colonization and disease | 000 | 2 | NIH | 3/26/2024 | $0 |
| | 2024 | 2022 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI156058 | Interaction of Galectin-9 and Pregnancy-Specific Glycoprotein 1 in the Regulation of Cells of the Innate and Adaptive Immune System | 000 | 2 | NIH | 3/26/2024 | $0 |
| | 2024 | 2022 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21CA257484 | Identifying EZH2-dependent vulnerabilities in RB deficient prostate cancer | 001 | 3 | NIH | 4/1/2024 | $33,446 |
| | 2024 | 2022 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI156402 | Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection | 000 | 2 | NIH | 4/3/2024 | $0 |
| | 2024 | 2022 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01OH012485 | Grief and health-related quality of life in WTCHR Survivors: Associations with bereavement, trauma exposures, and mental and physical health conditions | 00 | 3 | CDC | 4/2/2024 | $0 |
| | 2024 | 2021 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R00AA025403 | Presynaptic modulation of corticostriatal transmission following chronic ethanol exposure | 000 | 4 | NIH | 2/8/2024 | -$89,802 |
| | 2024 | 2021 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21NS121821 | A new Drosophila model of astrocyte calcium signaling in chronic pain | 000 | 1 | NIH | 4/15/2024 | -$6,392 |
| | 2024 | 2020 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21NS116710 | Characterization of neuronal derived exosomes to detect biomarkers for neurodegenerative disorders | 000 | 1 | NIH | 4/4/2024 | -$8,742 |
| | 2024 | 2019 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UG3DA048351 | INTERACT Meeting with FDA on Cohort Design and Development of ALFQ as an Adjuvant for Heroin Vaccine | 003 | 1 | NIH | 3/14/2024 | -$3,312 |
| | 2024 | 2019 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UG3DA048351 | INTERACT Meeting with FDA on Cohort Design and Development of ALFQ as an Adjuvant for Heroin Vaccine | 002 | 1 | NIH | 3/14/2024 | -$2,271 |
| | 2024 | 2019 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UG3DA048351 | INTERACT Meeting with FDA on Cohort Design and Development of ALFQ as an Adjuvant for Heroin Vaccine | 001 | 2 | NIH | 3/14/2024 | -$31,205 |
| | 2024 | 2019 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UG3DA048351 | INTERACT Meeting with FDA on Cohort Design and Development of ALFQ as an Adjuvant for Heroin Vaccine | 000 | 2 | NIH | 3/13/2024 | $0 |
| | 2024 | 2019 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01NS087575 | Functions of filamin in brain development and diseases | 000 | 5 | NIH | 2/7/2024 | -$296,186 |
|
| Issue Date FY: 2023 ( Subtotal = $30,901,217 ) (Continued on the next page) |
| | 2023 | 2023 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI174908 | A new strategy to eliminate HIV-1-infected cells by unlocking the Env trimer | 000 | 1 | NIH | 8/7/2023 | $716,299 |
| | 2023 | 2023 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI154619 | Respiratory mucosal immune development in early life and the quest for protective local memory against respiratory syncytial virus. | 000 | 3 | NIH | 4/19/2023 | $446,386 |
| | 2023 | 2023 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01AI170033 | Mitigation of Radiation Induced Immune Dysfunction by PrC-210 Treatment | 001 | 2 | NIH | 7/25/2023 | $99,997 |
| | 2023 | 2023 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01AI170033 | Mitigation of Radiation Induced Immune Dysfunction by PrC-210 Treatment | 000 | 2 | NIH | 5/25/2023 | $454,948 |
|
